REGISTERED
on 06 Feb 2024
Last Applicant/ Owned by
178 Versailles Ct
Newark
DE
19702
Serial Number
97417340 filed on 18th May 2022
Registration Number
7300620 registered on 06th Feb 2024
Filing Basis
1. intent to use
2. use application currently
Disclaimer
NO DATA
VITALIDEW
The wording VitaliDew has no meaning in a foreign language. Coenzyme Q10 dietary supplements; Dietary fiber to aid digestion; Dietetic preparations adapted for medical purposes; Enzyme dietary supplements; Nutraceuticals for use as a dietary supplement for promoting the growth of probiotics; Nutritional supplements; Pharmaceutical preparations for skin care; Sanitary napkins; Sanitary pads; Sanit Read More
Classification Information
Class [005]
Pharmaceutical Products
Coenzyme Q10 dietary supplements; Dietary fiber to aid digestion; Dietetic preparations adapted for medical purposes; Enzyme dietary supplements; Nutraceuticals for use as a dietary supplement for promoting the growth of probiotics; Nutritional supplements; Pharmaceutical preparations for skin care; Sanitary napkins; Sanitary pads; Sanitary towels; Slimming tea for medical purposes; Vitamin preparations
First Use Date in General
25th Aug 2022
First Use Date in Commerce
25th Aug 2022
Specimens
Mark Details
Serial Number
No 97417340
Mark Type
No Service/Collective Mark
Attorney Docket Number
No
44D Filed
No
44D Current
No
44E filed
No
44E Current
No
66A Filed
No
66A Current
No
Current Basis
No
No Basis
No
Legal History
| Status Date | Action Taken |
|---|---|
| 06th Feb 2024 | REGISTERED-PRINCIPAL REGISTER |
| 06th Feb 2024 | NOTICE OF REGISTRATION CONFIRMATION EMAILED |
| 30th Dec 2023 | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED |
| 29th Dec 2023 | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED |
| 13th Sep 2023 | STATEMENT OF USE PROCESSING COMPLETE |
| 08th Sep 2023 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
| 29th Aug 2023 | TEAS STATEMENT OF USE RECEIVED |
| 29th Aug 2023 | USE AMENDMENT FILED |
| 06th Jun 2023 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| 11th Apr 2023 | PUBLISHED FOR OPPOSITION |